The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Arris Group Inc New | COM | 04270V106 | 259,550 | 10,663,500 | SH | DFND | 2 | 0 | 10,663,500 | 0 | |
| Facebook Inc | CL A | 30303M102 | 1,379 | 25,231 | SH | DFND | 1 | 0 | 25,231 | 0 | |
| Foundation Medicine Inc | COM | 350465100 | 58,232 | 2,444,652 | SH | DFND | 1 | 0 | 2,444,652 | 0 | |
| RetailMeNot Inc | COM SER 1 | 76132B106 | 45,889 | 1,593,936 | SH | DFND | 1 | 0 | 1,593,936 | 0 | |